We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Anticoagulation in Patients with Dilated Cardiomyopathy, Low Ejection Fraction, and Sinus Rhythm: Back to the Drawing Board.
- Authors
Mischie, Alexandru Nicolae; Chioncel, Valentin; Droc, Ionel; Sinescu, Crina
- Abstract
Heart failure patients present an important thrombo-embolic risk, including symptomatic or silent peripheral arterial embolism, pulmonary embolism, and stroke. Patients in sinus rhythm who have concomitant depressed (<35%) left ventricular ejection fraction have a 4% rate of embolic events. Several prospective randomized trials of anticoagulation in this group of patients were either underpowered or had a short period of follow-up. Even though in two studies warfarin had a slight advantage over aspirin (in the WATCH and WARCEF trials), it was at the cost of an increased risk in major hemorrhage. To decrease bleeding rates and to improve anticoagulant effect, new treatment strategies have to be tested. Novel anticoagulants (dabigatran, rivaroxaban, and apixaban) seem to be a promising alternative.
- Subjects
HEART failure patients; DILATED cardiomyopathy; RIVAROXABAN; CLINICAL trials; ANTICOAGULANTS; HEMORRHAGE; THERAPEUTICS
- Publication
Cardiovascular Therapeutics, 2013, Vol 31, Issue 5, p298
- ISSN
1755-5914
- Publication type
Article
- DOI
10.1111/1755-5922.12019